Ignite Creation Date:
2024-05-05 @ 11:50 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00145678
Status:
COMPLETED
Last Update Posted:
2015-01-06
First Post:
2005-09-01
Brief Title:
Psychodynamic Therapy For Co-occurring Borderline Personality Disorder and Alcohol Use Disorder
Sponsor:
State University of New York - Upstate Medical University
Organization:
State University of New York - Upstate Medical University
Study Overview
Official Title:
Psychodynamic Therapy for Patients With Borderline Personality Disorder and Alcohol Abuse
Status:
COMPLETED
Status Verified Date:
2015-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of the study is to determine the feasibility and effectiveness of a modified form of psychodynamic psychotherapy for persons suffering from co-occurring borderline personality disorder and an alcohol use disorder
Detailed Description:
Borderline Personality Disorder BPD is a condition that can cause significant distress and increased risk of death Many persons with BPD also have an alcohol use disorder AUD and there is evidence that this can worsen the outcome and course of both disorders
A manual-based form of psychodynamic therapy PT labeled dynamic deconstructive psychotherapy has been developed for particularly challenging patients with BPD especially those with co-occurring substance use disorders It aims to remediate specific neurocognitive capacities that are responsible for processing of emotional experiences and so diminishes symptoms of BPD and promotes the development of a coherent and differentiated self-structure PT has been shown to be helpful for BPD but has not been tested for people who have BPD with co-occurring substance use disorders
The proposed study is a randomized controlled trial of PT for persons with BPD and co-occurring AUD that will generate some initial data that can be used to determine the need and feasibility for further outcome studies Participants are randomized to either a study group receiving weekly PT or to a control group receiving usual care Enrollment is 15 participants in each group The study group will receive 12-18 months of PT with naturalistic follow-up Outcome measures are administered by a research assistant at enrollment 3 months 6 months 9 months 12 months and 30 months
The investigators anticipate that the PT group will show trends towards better retention in treatment and greater reduction in parasuicides alcohol misuse and institutional care If so this would have important and positive implications for the large group of patients who suffer from BPD and co-occurring AUD
A manual-based form of psychodynamic therapy PT labeled dynamic deconstructive psychotherapy has been developed for particularly challenging patients with BPD especially those with co-occurring substance use disorders It aims to remediate specific neurocognitive capacities that are responsible for processing of emotional experiences and so diminishes symptoms of BPD and promotes the development of a coherent and differentiated self-structure PT has been shown to be helpful for BPD but has not been tested for people who have BPD with co-occurring substance use disorders
The proposed study is a randomized controlled trial of PT for persons with BPD and co-occurring AUD that will generate some initial data that can be used to determine the need and feasibility for further outcome studies Participants are randomized to either a study group receiving weekly PT or to a control group receiving usual care Enrollment is 15 participants in each group The study group will receive 12-18 months of PT with naturalistic follow-up Outcome measures are administered by a research assistant at enrollment 3 months 6 months 9 months 12 months and 30 months
The investigators anticipate that the PT group will show trends towards better retention in treatment and greater reduction in parasuicides alcohol misuse and institutional care If so this would have important and positive implications for the large group of patients who suffer from BPD and co-occurring AUD
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 130230-44 | None | None | None |